Insights

Health and Life Sciences icon

Reinvigorating action on antimicrobial resistance: where do the responsibilities lie?

Health and Life Sciences

Seon Jae Crystal Choi
|

Despite years of lobbying for awareness and action, recognition of the threat of antimicrobial resistance (AMR) is still lagging compared to its urgency. For example, a recent survey across 27 European countries showed that public awareness stood at just 30%. With 700,000 deaths every year attributed to AMR and expected to rise to 10 million by 2050, what practical…

Read more
Health and Life Sciences icon

National resistance to joint medical procurement: fractures in the European Health Union?

Health and Life Sciences

Saskia Hirsch
|

As European governments reflect on lessons from covid-19 to improve pandemic preparedness, the European Parliament and the Council of the European Union (EU) recently reached a provisional agreement on a new EU law on serious cross-border threats to health (CBTH). The legislation, which is part of a package of regulations for a European Health Union that aims to reinforce…

Read more
Health and Life Sciences icon

The geopolitics and implications of an international pandemic instrument

Health and Life Sciences

Seon Jae Crystal Choi
|

The first meeting of an intergovernmental negotiating body (INB) for an international instrument on pandemic prevention, preparedness and response, was held on 24th February 2022. The first of its kind, the instrument will be rooted in the World Health Organization (WHO) Constitution, thereby offering high-level mandates to its signatories. While strengthening global…

Read more